Literature DB >> 14623356

Reduced dopaminergic tone in hypothalamic neural circuits: expression of a "thrifty" genotype underlying the metabolic syndrome?

Hanno Pijl1.   

Abstract

The thrifty genotype hypothesis postulates that the genetically determined ability to grow obese and insulin resistant in times of food abundance confers a survival advantage in times of famine. Obviously, this ability poses a major health threat in modern times, where food is always available in large quantities. In the last 10-15 years, many genes encoding pathways that orchestrate energy balance and fuel flux have been discovered. This paper summarizes the evidence that diminished dopaminergic tone in hypothalamic nuclei contributes to the "thrifty" genotype/phenotype. Reduced dopaminergic neurotransmission in the suprachiasmatic nucleus of seasonally obese animals appears to drive noradrenalin and NPY mediated transmissions in other nuclei to induce the obesity syndrome at the appropriate time of year. Treatment with dopamine D(2) receptor agonists can fully reverse the metabolic syndrome in these animals. Similar mechanisms are operative in non-seasonal obese animal models. In man, treatment with dopamine D(2) receptor antagonists induces obesity and type 2 diabetes mellitus, whereas dopamine D(2) receptor activation ameliorates the metabolic profile in obese nondiabetic and diabetic humans. Various loss of function mutations of the dopamine D(2) receptor gene are associated with overweight in humans. In concert, the data support the notion that diminution of dopaminergic (dopamine D(2) receptor mediated) transmission in relevant hypothalamic nuclei sets the stage for efficient partitioning of ingested nutrients to contribute to a phenotype that is not so thrifty anymore.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14623356     DOI: 10.1016/j.ejphar.2003.08.100

Source DB:  PubMed          Journal:  Eur J Pharmacol        ISSN: 0014-2999            Impact factor:   4.432


  23 in total

1.  Leptin reduces food intake via a dopamine D2 receptor-dependent mechanism.

Authors:  Sonja K Billes; Stephanie E Simonds; Michael A Cowley
Journal:  Mol Metab       Date:  2012-07-27       Impact factor: 7.422

2.  Apo-ghrelin receptor forms heteromers with DRD2 in hypothalamic neurons and is essential for anorexigenic effects of DRD2 agonism.

Authors:  Andras Kern; Rosie Albarran-Zeckler; Heidi E Walsh; Roy G Smith
Journal:  Neuron       Date:  2012-01-26       Impact factor: 17.173

3.  Imaging of brain dopamine pathways: implications for understanding obesity.

Authors:  Gene-Jack Wang; Nora D Volkow; Panayotis K Thanos; Joanna S Fowler
Journal:  J Addict Med       Date:  2009-03       Impact factor: 3.702

4.  The influence of metabolic syndrome, physical activity and genotype on catechol-O-methyl transferase promoter-region methylation in schizophrenia.

Authors:  S A Lott; P R Burghardt; K J Burghardt; M J Bly; T B Grove; V L Ellingrod
Journal:  Pharmacogenomics J       Date:  2012-03-06       Impact factor: 3.550

5.  Reduction of renal dopamine receptor expression in obese Zucker rats: role of sex and angiotensin II.

Authors:  Xiaoyan Wang; Fengmin Li; Pedro A Jose; Carolyn M Ecelbarger
Journal:  Am J Physiol Renal Physiol       Date:  2010-09-01

Review 6.  The psychopharmacotherapy of anorexia nervosa: clinical, neuroendocrine and metabolic aspects.

Authors:  G Abbate Daga; L Gianotti; V Mondelli; R Quartesan; S Fassino
Journal:  J Endocrinol Invest       Date:  2004-11       Impact factor: 4.256

7.  Alterations of central dopamine receptors before and after gastric bypass surgery.

Authors:  Kimberley E Steele; Gregory P Prokopowicz; Michael A Schweitzer; Thomas H Magunsuon; Anne O Lidor; Hiroto Kuwabawa; Anil Kumar; James Brasic; Dean F Wong
Journal:  Obes Surg       Date:  2009-10-29       Impact factor: 4.129

8.  Arcuate nucleus expression of NKX2.1 and DLX and lineages expressing these transcription factors in neuropeptide Y(+), proopiomelanocortin(+), and tyrosine hydroxylase(+) neurons in neonatal and adult mice.

Authors:  Cindy L Yee; Yanling Wang; Stewart Anderson; Marc Ekker; John L R Rubenstein
Journal:  J Comp Neurol       Date:  2009-11-01       Impact factor: 3.215

9.  Basal serum prolactin levels in obesity--unrelated to parameters of the metabolic syndrome and unchanged after massive weight loss.

Authors:  Barbara Ernst; Martin Thurnheer; Bernd Schultes
Journal:  Obes Surg       Date:  2009-05-09       Impact factor: 4.129

10.  Glucose and fat metabolism in narcolepsy and the effect of sodium oxybate: a hyperinsulinemic-euglycemic clamp study.

Authors:  Claire E H M Donjacour; N Ahmad Aziz; Sebastiaan Overeem; Andries Kalsbeek; Hanno Pijl; Gert Jan Lammers
Journal:  Sleep       Date:  2014-04-01       Impact factor: 5.849

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.